How is DSM creating new opportunities for innovation in the cannabinoid pharmaceuticals market?

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email



DSM recently announced that it will be taking its first steps into the cannabinoid API market via a commercial partnership with global pioneer in cannabinoid APIs, Brains Bioceutical. In our recent interview, Kelsey Achenbach – Senior Director Pharma and Medical Nutrition, DSM – explains why the company is extending its pharmaceutical portfolio to include high-quality cannabinoid actives, and how this is creating opportunities for Rx pharmaceutical manufacturers to expand into new therapeutic fields by innovating with cannabinoids.

View original source video by clicking here

On Key

Related Posts

The strains that made Cookies

When it comes to cannabis culture and products, few names ring off in the streets like Cookies. Its genetics have been used to create some

5 MIN WARM UP FOR AT HOME WORKOUTS (No Jumping)

Join me in this 5 min APARTMENT FRIENDLY (no jumping) warm up routine for at home workouts! Warming up is so important and you should be warming up before EVERY single workout! DOWNLOAD YOUR MADFIT APP FREE TRIAL HERE: https://madfit.app.link/e/store #WithMe #WarmUp #HomeWorkout THE MAT I USE (Exercise 6X4): http://gorillamats.com?aff=19 (MADFIT10 for 10% off) SUBSCRIBE…